- Home
- TAOP vs SLRX Comparison
TAOP vs SLRX Comparison
Compare TAOP & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- SLRX
- Stock Information
- Founded
- TAOP 1993
- SLRX N/A
- Country
- TAOP China
- SLRX United States
- Employees
- TAOP N/A
- SLRX N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- SLRX Health Care
- Exchange
- TAOP Nasdaq
- SLRX Nasdaq
- Market Cap
- TAOP 2.2M
- SLRX 2.0M
- IPO Year
- TAOP N/A
- SLRX N/A
- Fundamental
- Price
- TAOP $0.32
- SLRX $1.22
- Analyst Decision
- TAOP
- SLRX
- Analyst Count
- TAOP 0
- SLRX 0
- Target Price
- TAOP N/A
- SLRX N/A
- AVG Volume (30 Days)
- TAOP 1.3M
- SLRX 30.5K
- Earning Date
- TAOP 09-05-2024
- SLRX 11-14-2024
- Dividend Yield
- TAOP N/A
- SLRX N/A
- EPS Growth
- TAOP N/A
- SLRX N/A
- EPS
- TAOP 0.50
- SLRX N/A
- Revenue
- TAOP $42,636,173.00
- SLRX N/A
- Revenue This Year
- TAOP N/A
- SLRX N/A
- Revenue Next Year
- TAOP N/A
- SLRX N/A
- P/E Ratio
- TAOP $0.51
- SLRX N/A
- Revenue Growth
- TAOP 37.49
- SLRX N/A
- 52 Week Low
- TAOP $0.30
- SLRX $1.22
- 52 Week High
- TAOP $2.01
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- TAOP 33.90
- SLRX 35.59
- Support Level
- TAOP $0.30
- SLRX $1.35
- Resistance Level
- TAOP $0.40
- SLRX $1.67
- Average True Range (ATR)
- TAOP 0.04
- SLRX 0.12
- MACD
- TAOP 0.00
- SLRX -0.02
- Stochastic Oscillator
- TAOP 16.00
- SLRX -15.38
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.